Messenger ribonucleic acid (mrna) synthesis and manufacturing market to reach $9.22 billion by 2030 at 12.3% CAGR, driven by increasing prevalence of infectious diseases.
Read More
Messenger ribonucleic acid (mrna) capping enzyme market to reach $1.97 billion by 2030 at 14.1% CAGR, driven by growing adoption of personalized medicine.
Read More
Men’s health supplements market to reach $148.91 billion by 2030 at 11.4% CAGR, driven by increase in disposable income.
Read More
Menopause supplement market to reach $2.98 billion by 2030 at 7.7% CAGR, driven by rising prevalence of menopausal symptoms.
Read More
Oral biologics & biosimilars market to reach $24.69 billion by 2030 at 21.6% cagr, driven by rising prevalence of chronic diseases.
Read More
Oral biologics & biosimilar drugs market to reach $17.17 billion by 2030 at 13.3% cagr, driven by rising prevalence of chronic diseases.
Read More
The global oral antidiabetic drugs market to reach $92.64 billion by 2030 at 6.7% cagr, driven by increasing type 2 diabetes.
Read More
The global opioids market to reach $28.59 billion by 2030 at 3.8% cagr, driven by increasing prevalence of chronic diseases.
Read More
Ophthalmic drugs market to reach $61.21 billion by 2030 at 7.9% cagr, driven by increase in the prevalence of ophthalmic disorders.
Read More
Oncology precision medicine market to reach $226.55 billion by 2030 at 12.5% cagr, driven by growing prevalence of cancer.
Read More